title: [What is assured in therapy with HMG-CoA reductase inhibitors (cholesterol synthesis inhibitors)?].
authors.affiliation: Abteilung Innere Medizin IV, Medizinische Klinik und Poliklinik, Universität Tübingen.
authors.forename: W
authors.initials: W
authors.lastname: Knisel
authors.forename: M
authors.initials: M
authors.lastname: Eggstein
mesh_terms: D002784:Cholesterol / Q000097:blood; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006937:Hypercholesterolemia / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D013329:Structure-Activity Relationship
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D002784:Cholesterol
vernacular_title: Was ist gesichert in der Therapie mit HMG-CoA-Reduktasehemmern (Cholesterinsynthesehemmern)?